Convalescent plasma does not improve outcomes in patients hospitalized with severe COVID-19 pneumonia (PlasmAr) QuestionDoes convalescent plasma improve outcomes in patients hospitalized with severe pneumonia due to SARS-CoV-2?ConclusionIn this study, convalescent plasma did not improve outcomes in patients hospitalized with severe COVID-19 pneumonia.Reference Simonovich VA, Burgos Pratx LD, Scibona P, et al, for the PlasmAr Study Group. A randomized trial of convalescent plasma in Covid-19 severe pneumonia. N Engl J Med 2021;384(7):619-629. Share This Post! Search for: Popular Recent Comments Convalescent plasma does not improve outcomes in patients hospitalized with severe COVID-19 pneumonia (PlasmAr) May 17th, 2021 Giant cell (temporal) arteritis: No laboratory test or physical finding is pathognomic March 8th, 2021 Musculoskeletal surgery for nontraumatic pain: not a great analgesic March 15th, 2021 Convalescent plasma does not improve outcomes in patients hospitalized with severe COVID-19 pneumonia (PlasmAr) May 17th, 2021 Tofacitinib Does Not Increase Risk of Venous Thromboembolism in Patients With RA May 10th, 2021 Tocilizumab and sarilumab are effective for critically ill patients with COVID-19 who require organ support May 3rd, 2021 No comments have been published yet. Recent Posts Convalescent plasma does not improve outcomes in patients hospitalized with severe COVID-19 pneumonia (PlasmAr) Tofacitinib Does Not Increase Risk of Venous Thromboembolism in Patients With RA Tocilizumab and sarilumab are effective for critically ill patients with COVID-19 who require organ support Single-dose opioid analgesics offer no benefit over non-narcotic analgesia for musculoskeletal pain SR: Exercise is the only intervention to provide long-term improvement in patients with chronic low back pain ADARRC2021-05-22T15:36:37+04:00 Related Posts Tofacitinib Does Not Increase Risk of Venous Thromboembolism in Patients With RA Gallery Tofacitinib Does Not Increase Risk of Venous Thromboembolism in Patients With RA May 10th, 2021 | 0 Comments Tocilizumab and sarilumab are effective for critically ill patients with COVID-19 who require organ support Gallery Tocilizumab and sarilumab are effective for critically ill patients with COVID-19 who require organ support May 3rd, 2021 | 0 Comments Single-dose opioid analgesics offer no benefit over non-narcotic analgesia for musculoskeletal pain Gallery Single-dose opioid analgesics offer no benefit over non-narcotic analgesia for musculoskeletal pain April 26th, 2021 | 0 Comments Leave A Comment Cancel replyComment Save my name, email, and website in this browser for the next time I comment.
